Biotech

All Articles

OS Therapies refiles $6M IPO to finance HER2 medicine, preclinical ADCs

.Operating system Therapies will list on the NYSE American supply substitution this morning via a $6...

ALX's fizzling CD47 action cost sends out inventory spiraling down

.ALX Oncology's phase 2 stomach cancer reaction price has actually weakened. After finding its CD47 ...

Ionis axes eye health condition coming from intendeds of Roche-partnered possibility after data disappoint

.Yet Another of Ionis Pharmaceuticals' essential midphase readouts has actually disappointed desires...

Biogen's chief executive officer said no risky handle 2023. He prepares to become vibrant

.While Biogen's pharma peers are actually searching for late-stage properties along with little bit ...

Instil refills pipe in $2B biobucks cope with ImmunOnco

.Instil Bio has been a biotech seeking a pipe after it junked its own lead properties over the final...

Biogen ignores Denali Alzheimer's collab

.Biogen has handed back liberties to an early Alzheimer's disease system to Denali Rehabs, leaving a...

Takeda water faucets brand-new mind of US oncology business-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of considerable management hirings, firings ...

Vertex, hammered by AATD once again, drops 2 properties on throw out pile

.Vertex's effort to alleviate an uncommon genetic illness has actually attacked one more trouble. Th...

Vir increases 3 T-cell engagers from Sanofi, gives up 25% of staff

.Vir Biotechnology's second-quarter earnings file wasn't except significant news. The provider accep...

Galapagos stops briefly CAR-T tissue treatment hearing over Parkinsonism instance

.Galapagos has actually stopped briefly registration in a trial of a BCMA-directed CAR-T cell therap...